Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Head and Neck Cancer

 

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (7797)
A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Investigator: Renato G. Martins, MD, MPH;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01412229

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, or Head and Neck Cancer
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Head and Neck Cancer

Investigator: John A. Thompson, MD;   Conditions: Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01727076

MPDL3280A + Cobimetinib for Locally Advanced or Metastatic Cancer
A Phase 1b Study of the Safety and Pharmacology of MPDL3280A Administered With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors

Investigator: Laura Chow, MD;   Conditions: Neoplasms;    Status: Recruiting;   Study ID: NCT01988896

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas (14032)
A Phase 2, Open-Label Study of the Safety and Efficacy of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck, Lung, or Esophagus (STARRS)

Investigator: Cristina Rodriguez, MD;   Conditions: Advanced Squamous Cell Carcinoma of Head and Neck, Lung, or Esophagus;    Status: Pending;   Study ID: NCT02213133

SGX942 for Oral Mucositis in Patients With Head and Neck Cancer (20131334)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Multicenter Study Of SGX942 For The Attenuation Of Oral Mucositis In Patients Being Treated With Concomitant Chemoradiation (CRT) For The Treatment Of Squamous Cell Carcinoma Of The Head And Neck

Investigator: Jay Liao, MD;   Conditions: Head & Neck Cancer;    Status: Recruiting;   Study ID: NCT02013050